文献速递慢性肾脏病肾血管病与高血压肾小球疾病

肾功能作为老年人心血管结局与死亡的风险因素及预测指标

Kidney Function as Risk Factor and Predictor of Cardiovascular Outcomes and Mortality Among Older Adults.
PubMed 文献 · Am J Kidney Dis · 2020-11-14

这项基于柏林倡议研究(BIS)的队列研究纳入1581例≥70岁无卒中/心梗史老年人,中位随访8.2年。发现eGFR 45-59 mL/min/1.73m²(vs >60)与卒中相关(HR 2.23),但UACR 30-300 mg/g与心梗(HR 1.65)和全因死亡(HR 1.63)相关,且基于胱抑素C的eGFR可改善卒中风险预测。

要点

  • 老年人eGFR 45-59 mL/min/1.73m²且无白蛋白尿时,卒中风险独立增加。
  • UACR 30-300 mg/g与心梗和全因死亡风险升高相关,但与卒中无关。
  • 基于胱抑素C的eGFR方程可改善老年人卒中风险预测。

核心结论

  • 在≥70岁无卒中/心梗史人群中,eGFR 45-59 mL/min/1.73m²与卒中风险升高独立相关,但与心梗或全因死亡无关。
  • UACR 30-300 mg/g与心梗和全因死亡风险升高相关,但与卒中无关。
  • 基于胱抑素C的eGFR方程可改善该人群的卒中风险预测。

研究设计与样本

  • 人群为基础的前瞻性队列研究(柏林倡议研究BIS),纳入1581例年龄≥70岁且无既往卒中或心梗的参与者。
  • 暴露包括基于血清肌酐和胱抑素C的eGFR、UACR分类及实测GFR(n=436)。
  • 采用多变量校正Cox比例风险模型计算HR和95%CI,并评估NRI和C统计量差异。

主要发现

  • 中位随访8.2年期间,发生193例卒中、125例心梗和531例死亡。
  • 校正UACR后,eGFR 45-59 mL/min/1.73m²(vs >60)与卒中相关(HR 2.23;95%CI 1.55-3.21),与心梗或全因死亡无关。
  • eGFR<45 mL/min/1.73m²者,卒中HR 1.99(95%CI 1.23-3.20),心梗HR 1.38(95%CI 0.81-2.36),全因死亡HR 1.57(95%CI 1.20-2.06)。
  • 与UACR<30 mg/g相比,UACR 30-300 mg/g与卒中无关(HR 0.91;95%CI 0.63-1.33),但与心梗(HR 1.65;95%CI 1.09-2.51)和全因死亡(HR 1.63;95%CI 1.34-1.98)相关。
  • 卒中预测分析显示,基于胱抑素C的CKD-EPI方程、基于肌酐和胱抑素C的BIS方程及Full Age Spectrum方程计算的eGFR均具有显著正向NRI;UACR对心梗和死亡显示显著正向NRI。

关键数值与推荐

  • eGFR 45-59 mL/min/1.73m²(vs >60)与卒中相关HR 2.23(95%CI 1.55-3.21)。
  • eGFR<45 mL/min/1.73m²与卒中HR 1.99(95%CI 1.23-3.20)、全因死亡HR 1.57(95%CI 1.20-2.06)。
  • UACR 30-300 mg/g(vs <30)与心梗HR 1.65(95%CI 1.09-2.51)、全因死亡HR 1.63(95%CI 1.34-1.98)。

临床怎么用

  • 对≥70岁老年人,eGFR 45-59 mL/min/1.73m²且无白蛋白尿时,应关注卒中风险。
  • UACR 30-300 mg/g提示心梗和全因死亡风险升高,需加强心血管风险管理。
  • 基于胱抑素C的eGFR可能有助于改善老年人卒中风险预测。

局限性

  • eGFR和UACR分类基于单次检测。
  • 缺乏死因特异性死亡数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Estimated glomerular filtration rate (eGFR) and urinary albumin-creatinine ratio (UACR) are associated with cardiovascular events in the general population but their utility among older adults is unclear. We investigated the associations of eGFR and UACR with stroke, myocardial infarction (MI), and death among older adults. STUDY DESIGN: Population-based cohort study. SETTING & PARTICIPANTS: 1,581 participants (aged≥70 years) in the Berlin Initiative Study (BIS) without prior stroke or MI. EXPOSURES & PREDICTORS: Serum creatinine- and cystatin C-based eGFR, UACR categories, and measured GFR (n=436). OUTCOMES: Stroke, MI, and all-cause mortality. ANALYTICAL APPROACH: HRs and 95% CIs derived from multivariable-adjusted Cox proportional hazards models for association analyses. Net reclassification improvement (NRI) and C statistic differences comparing the predictive benefit of kidney measures with a traditional cardiovascular risk model. RESULTS: During a median follow-up of 8.2 years, 193 strokes, 125 MIs, and 531 deaths occurred. Independent of UACR, when GFR was estimated using the creatinine- and cystatin C-based BIS equation, eGFR of 45 to 59mL/min/1.73m2 (vs eGFR>60mL/min/1.73m2) was associated with stroke (HR, 2.23; 95% CI, 1.55-3.21) but not MI or all-cause mortality. For those with eGFR<45mL/min/1.73m2, the HRs were 1.99 (95% CI, 1.23-3.20) for stroke, 1.38 (95% CI, 0.81-2.36) for MI, and 1.57 (95% CI, 1.20-2.06) for mortality. Compared with UACR<30mg/g, UACR of 30 to 300mg/g was not associated with stroke (HR, 0.91; 95% CI, 0.63-1.33) but was associated with MI (HR, 1.65; 95% CI, 1.09-2.51) and all-cause mortality (HR, 1.63; 95% CI, 1.34-1.98). Prediction analysis for stroke showed significant positive NRI for eGFR calculated using the cystatin C-based Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation and the creatinine- and cystatin C-based BIS and Full Age Spectrum equations. UACR demonstrated significant positive NRIs for MI and mortality. LIMITATIONS: eGFR and UACR categorization based on single assessments; lack of cause-specific death data. CONCLUSIONS: eGFR of 45 to 59mL/min/1.73m2 without albuminuria was associated with stroke but not MI or all-cause mortality in older adults. In contrast, UACR of 30 to 300mg/g was associated with MI and all-cause mortality but not with stroke. Furthermore, cystatin C-based eGFR improved risk prediction for stroke in this cohort of older adults.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Kühn A, van der Giet M, Kuhlmann MK, et al. Kidney Function as Risk Factor and Predictor of Cardiovascular Outcomes and Mortality Among Older Adults. Am J Kidney Dis. 2020. PMID: 33197533. doi:10.1053/j.ajkd.2020.09.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。